Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.49 |
| ▸ | ACP1 | P24666 | 1/20 | 0.49 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.49 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.49 |
| ▸ | PNPO | Q9NVS9 | 1/20 | 0.48 |
| ▸ | TKT | P29401 | 5/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL851328 | 0.88 | LMNA (0.57) | LMNATDP1ESR1PTGS1ACP1 | |
| Pyrophosphoric Acid SCHEMBL851327 | 0.80 | LMNA (0.51) | LMNATDP1TKT | |
| SCHEMBL5916304 | 0.79 | LMNA (0.50) | LMNATDP1TKTCYP3A4CYP2C19 | |
| Phosphoric Acid SCHEMBL1533803 | 0.79 | LMNA (0.53) | LMNATDP1TKT | |
| Phosphoric Acid SCHEMBL851329 | 0.79 | LMNA (0.53) | LMNATDP1TKT | |
| SCHEMBL849877 | 0.79 | LMNA (0.53) | LMNATDP1TKT | |
| SCHEMBL7607052 | 0.76 | LMNA (1.00) | LMNATKT | |
| SCHEMBL18987265 | 0.74 | LMNA (0.65) | LMNATKT | |
| SCHEMBL20323319 | 0.74 | ESR1 (0.66) | LMNATDP1ESR1PTGS1ACP1 | |
| SCHEMBL12346332 | 0.74 | LMNA (0.63) | LMNATKT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | claimed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | claimed |
| CN-119731312-A | Microbial cell factory for producing thiamine | 拜奥信尼亚私营有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| US-20240368659-A1 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2024-11-07 | — | — | US | claimed |
| EP-4370653-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | Biosyntia ApS (DK) | 2024-05-22 | — | — | EP | claimed |
| WO-2024013212-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2024-01-18 | — | — | WO | claimed |
| WO-2023285585-A2 | MICROBIAL CELL FACTORIES PRODUCING VITAMIN B COMPOUNDS | BIOSYNTIA APS (DK) | 2023-01-19 | — | — | WO | claimed |
| US-10696992-B2 | Genetically modified bacterial cell factory for thiamine production | BIOSYNTHIA APS (DK) | 2020-06-30 | — | — | US | claimed |
| EP-3390618-B1 | A GENETICALLY MODIFIED BACTERIAL CELL FACTORY FOR THIAMINE PRODUCTION | BIOSYNTIA APS (DK) | 2020-04-22 | — | — | EP | claimed |
| EP-3390618-A1 | A GENETICALLY MODIFIED BACTERIAL CELL FACTORY FOR THIAMINE PRODUCTION | Biosyntia ApS (DK) | 2018-10-24 | — | — | EP | claimed |
| WO-2017103221-A1 | A GENETICALLY MODIFIED BACTERIAL CELL FACTORY FOR THIAMINE PRODUCTION | BIOSYNTIA APS (DK) | 2017-06-22 | — | — | WO | claimed |
| EP-1093520-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | Syngenta Participations AG (CH) | 2001-04-25 | — | — | EP | claimed |
| WO-2000000623-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | SYNGENTA PARTICIPATIONS AG (CH) | 2000-01-06 | — | — | WO | claimed |
| WO-2026099311-A2 | MICROBIAL CELL FACTORIES PRODUCING PROSTAGLANDINS | RIVER STONE BIOTECH APS (DK) | 2026-05-15 | — | — | WO | disclosed |
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | BIOSYNTIA APS (DK) | 2026-01-22 | — | — | US | disclosed |
| EP-4555076-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | Biosyntia ApS (DK) | 2025-05-21 | — | — | EP | disclosed |
| US-20060127993-A1 | Thiamin production by fermentation | DSM IP ASSETS B.V. (NL) | 2006-06-15 | — | — | US | disclosed |
| US-20050287169-A1 | Methods of use of genes of pyridoxal 5'-phosphate biosynthesis in Bacillus subtilis: avirulent strains for vaccines, and methods for identification of antibacterial agents | NATIONAL SCIENCE FOUNDATION | 2005-12-29 | — | — | US | disclosed |
| EP-1093520-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | Syngenta Participations AG (CH) | 2001-04-25 | — | — | EP | disclosed |
| WO-2000000623-A1 | HMP-P KINASE AND TMP-PPASE FROM ARABIDOPSIS THALIANA AND THEIR USE IN HERBICIDE SCREENING | SYNGENTA PARTICIPATIONS AG (CH) | 2000-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022411-A1 | MICROBIAL CELL FACTORIES PRODUCING THIAMINE | AHCY, SHMT1, MTHFD1 | LMNA 4260/4885TDP1 1224/4885ESR1 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.